Asan Medical Center Myocardial Infarction Registry
Launched by SEUNG-JUNG PARK · Jan 21, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Asan Medical Center Myocardial Infarction Registry is a study aimed at understanding the long-term outcomes of patients who have experienced an acute heart attack (also called myocardial infarction) and received various treatments, including medications, coronary artery bypass surgery, or a procedure known as percutaneous coronary intervention. This research is taking place at Asan Medical Center in Korea and is currently looking for participants.
To be eligible for this study, patients must have been diagnosed with an acute heart attack through a specific heart imaging test called coronary angiography. The trial is open to adults of all ages and genders. If you choose to participate, you will be contributing to important research that seeks to improve the care and treatment of heart attack patients. Your involvement may include follow-up assessments to monitor your health over time, helping doctors learn more about how different treatments affect recovery and long-term health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All consecutive acute myocardial infarction patients diagnosed through coronary angiography
About Seung Jung Park
Seung-Jung Park is a distinguished clinical trial sponsor recognized for his commitment to advancing medical research and innovation. With a focus on cardiology and interventional procedures, he leads initiatives that aim to improve patient outcomes through rigorous clinical trials. His expertise in trial design and execution ensures adherence to the highest ethical standards and regulatory requirements. By fostering collaboration among multidisciplinary teams, Seung-Jung Park drives the development of cutting-edge therapies, contributing significantly to the scientific community and enhancing the landscape of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials